Internal Medicine, Rheumatology · Honolulu, HI
NPI
1083833388
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2828 Paa St
Honolulu, HI, 96819
Phone (808) 432-5777
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,317
55 services
Medicare patients, 2024
21
Average age 69
Drug cost, 2024
$1.5M
1,901 prescriptions
Company payments, 2025
$116
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michiko Inaba was code 99214 (office e&m - established), 25 times for 13 patients. In total Michiko Inaba billed 55 services in 11 codes, and Medicare paid $3,317.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 25 | 13 | $63.33 | $1,583 |
By year: 2022 $4,826 for 145 services; 2023 $3,760 for 105 services; 2024 $3,317 for 55 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michiko Inaba prescribed most often to Medicare patients was Prednisone, with 266 prescriptions and refills. In total Michiko Inaba wrote 1,901 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 266 | 480 | 96 | $2,447 |
| Methotrexate Methotrexate Sodium | 265 | 733 | 83 | $5,037 |
| Hydroxychloroquine Sulfate Generic | 168 | 478 | 51 | $4,912 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 144 | 180 | 29 | $200K |
| Leflunomide Generic | 107 | 292 | 39 | $2,625 |
| Otezla Apremilast | 57 | 57 | Under 11 | $241K |
| Sulfasalazine Dr Sulfasalazine | 55 | 158 | 19 | $3,985 |
| Gabapentin Generic | 51 | 107 | 25 | $1,069 |
| Alendronate Sodium Generic | 47 | 127 | 13 | $454 |
| Diclofenac Sodium Generic | 42 | 50 | 32 | $3,351 |
| Allopurinol Generic | 38 | 108 | 16 | $375 |
| Duloxetine Hcl Generic | 30 | 79 | Under 11 | $602 |
| Mycophenolate Mofetil Generic | 28 | 80 | Under 11 | $2,975 |
| Xeljanz Tofacitinib Citrate | 27 | 28 | Under 11 | $122K |
| Xeljanz Xr Tofacitinib Citrate | 26 | 26 | Under 11 | $130K |
Brand drugs: 544 claims; generic drugs: 1,327 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michiko Inaba $116 ($116 in general payments such as food, travel and fees) from 1 company. The largest payer was Genzyme Corporation with $116.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.